These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Use of tacrolimus and mycophenolate mofetil as induction and maintenance in simultaneous pancreas-kidney transplantation. Ciancio G, Lo Monte A, Buscemi G, Miller J, Burke GW. Transpl Int; 2000; 13 Suppl 1():S191-4. PubMed ID: 11111994 [Abstract] [Full Text] [Related]
9. Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. Mehra MR, Uber PA, Scott RL, Park MH. Transplantation; 2002 Dec 15; 74(11):1568-73. PubMed ID: 12490790 [Abstract] [Full Text] [Related]
13. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy. Schwarz C, Regele H, Huttary N, Wahrmann M, Exner M, Nagy-Bojarsky K, Kletzmayr J, Hörl WH, Böhmig GA. Wien Klin Wochenschr; 2006 Jul 15; 118(13-14):397-404. PubMed ID: 16865644 [Abstract] [Full Text] [Related]
14. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up. Ciancio G, Burke GW, Gaynor JJ, Roth D, Sageshima J, Kupin W, Tueros L, Hanson L, Rosen A, Ruiz P, Miller J. Transplantation; 2008 Jul 15; 86(1):67-74. PubMed ID: 18622280 [Abstract] [Full Text] [Related]
15. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. Jain AB, Hamad I, Rakela J, Dodson F, Kramer D, Demetris J, McMichael J, Starzl TE, Fung JJ. Transplantation; 1998 Nov 27; 66(10):1395-8. PubMed ID: 9846530 [Abstract] [Full Text] [Related]